(Q33250003)

24 July 2017

0 references

A meta-analysis: comparison of esomeprazole and other proton pump inhibitors in eradicating Helicobacter pylori (English)

1 reference

Helicobacter pylori infectious disease

24 July 2017

0 references

1 reference

1 reference

1 reference

Xia Wang

1

1 reference

24 July 2017

Jing-Yuan Fang

series ordinal

2

1 reference

24 July 2017

Rong Lu

series ordinal

3

1 reference

24 July 2017

Dan-Feng Sun

series ordinal

4

1 reference

24 July 2017

publication date

11 July 2006

1 reference

24 July 2017

1 reference

24 July 2017

volume

73

1 reference

24 July 2017

issue

2-3

1 reference

24 July 2017

page(s)

178-186

1 reference

A pharmacokinetic study comparing single and repeated oral doses of 20 mg and 40 mg omeprazole and its two optical isomers, S-omeprazole (esomeprazole) and R-omeprazole, in healthy subjects

24 July 2017

cites work

1 reference

Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses

21 January 2018

1 reference

A prospective randomized trial of esomeprazole- versus pantoprazole-based triple therapy for Helicobacter pylori eradication

21 January 2018

1 reference

Esomeprazole 40 mg twice daily in triple therapy and the efficacy of Helicobacter pylori eradication related to CYP2C19 metabolism

21 January 2018

1 reference

Esomeprazole versus omeprazole for the eradication of Helicobacter pylori infection: results of a randomized controlled study

21 January 2018

1 reference

Esomeprazole‐based one‐week triple therapy with clarithromycin and metronidazole is effective in eradicating Helicobacter pylori in the absence of antimicrobial resistance

21 January 2018

1 reference

One-week triple therapy with esomeprazole, clarithromycin and metronidazole provides effective eradication of Helicobacter pylori infection

21 January 2018

1 reference

One week of treatment with esomeprazole-based triple therapy eradicates Helicobacter pylori and heals patients with duodenal ulcer disease

21 January 2018

1 reference

Systematic review and meta-analysis: is 1-week proton pump inhibitor-based triple therapy sufficient to heal peptic ulcer?

21 January 2018

1 reference

Meta-analysis: comparative efficacy of different proton-pump inhibitors in triple therapy for Helicobacter pylori eradication

21 January 2018

1 reference

Role of systematic reviews and meta-analysis in evidence-based medicine

21 January 2018

1 reference

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

Helicobacter pylori infection and the development of gastric cancer

21 January 2018

1 reference

High eradication rates of Helicobacter pylori infection with first- and second-line combination of esomeprazole, tetracycline, and metronidazole in patients allergic to penicillin

21 January 2018

1 reference

Antimicrobial activity of esomeprazole versus omeprazole against Helicobacter pylori

21 January 2018

1 reference

Dual vs. triple therapy for childhood Helicobacter pylori gastritis: a double-blind randomized multicentre trial

21 January 2018

1 reference

Esomeprazole-based therapy in Helicobacter pylori eradication: any effect by increasing the dose of esomeprazole or prolonging the treatment?

21 January 2018

1 reference

Comparison of H2-receptor antagonist- and proton-pump inhibitor-based triple regimens for the eradication of Helicobacter pylori in Chinese patients with gastritis or peptic ulcer

21 January 2018

1 reference

Meta-analysis: proton pump inhibitors vs. H2-receptor antagonists--their efficacy with antibiotics in Helicobacter pylori eradication

21 January 2018

1 reference

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000094526

1 reference

24 July 2017

1 reference